(NP (NP (NN Synergism)) (PP (IN between) (NP (NP (CD two) (JJ distinct) (NNS elements)) (PP (IN of) (NP (DT the) (NN HTLV-I) (NN enhancer))))) (PP-TMP (IN during) (NP (NP (NN activation)) (PP (IN by) (NP (NP (DT the) (NN trans-activator)) (PP (IN of) (NP (NN HTLV-I))))))) (. .))
(S (NP-SBJ-11 (PRP We)) (VP (VBP have) (VP (VBN conducted) (NP (NP (JJ functional) (NNS studies)) (PP (IN of) (NP (NP (DT the) (NN enhancer) (NNS elements)) (PP (IN of) (NP (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD I)) (PRN (-LRB- -LRB-) (NP (NN HTLV-I)) (-RRB- -RRB-))))))) (S (NP-SBJ (-NONE- *-11)) (VP (VBG using) (NP (DT the) (JJ human) (NN T-cell) (NNS lines) (NP-COOD (NP (NP-COOD (NP (NN Jurkat)) (CC and) (NP (NN MOLT) (CD 4))) (, ,) (SBAR (WHNP-12 (WDT which)) (S (NP-SBJ (-NONE- *T*-12)) (VP (VBP are) (ADJP-PRD (JJ negative) (PP (IN for) (NP (NN HTLV-I))))))) (, ,)) (CC and) (NP (NP-COOD (NP (NN MT-2)) (CC and) (NP (NN TL-Mor))) (, ,) (SBAR (WHNP-13 (WDT which)) (S (NP-SBJ (-NONE- *T*-13)) (VP (VBP carry) (NP (NP (DT the) (JJ proviral) (NN genome)) (PP (IN of) (NP (NN HTLV-I)))))))))))))) (. .))
(S (NP-SBJ-14 (CD Two) (JJ distinct) (NNS elements)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (NP (-NONE- *-14)) (PP (IN in) (NP (NP (NN function)) (PP (IN of) (NP (DT the) (NN HTLV-I) (NN enhancer)))))))) (. .))
(S (NP-SBJ (CD One)) (VP (VBZ is) (NP-PRD (NP (DT the) (ADJP (JJ 21-base-pair) (PRN (-LRB- -LRB-) (NP (NN bp)) (-RRB- -RRB-))) (NN core) (NN element)) (SBAR-COOD (SBAR (WHNP-15 (WDT that)) (S (NP-SBJ (-NONE- *T*-15)) (VP (VBZ is) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NP (NN trans-activation)) (PP (IN by) (NP (DT the) (NN HTLV-I) (NN trans-activator) (NN p40tax))))))))) (CC and) (SBAR (WHNP-16 (WDT that)) (S (NP-SBJ (-NONE- *T*-16)) (VP (VBZ has) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB bind) (PP (TO to) (NP (ADJP (NN cyclic-AMP) (JJ responsive) (NN element) (NN binding) (NN factor) (-LRB- -LRB-) (NN CREB) (-RRB- -RRB-) (JJ -like)) (NN factor) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-))))))))))))) (. .))
(S (NP-SBJ (DT The) (JJ other)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN region)) (ADJP (VBN interposed) (PP (IN between) (NP (DT the) (JJ 21-bp) (NNS elements)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-100 (NP (NP (DT a) (NN subfragment)) (PRN (-LRB- -LRB-) (NP (NN C26)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NN region)) (PP (IN between) (NP (DT the) (JJ 21-bp) (NNS elements)))))) (VP (VBZ is) (VP (VBN involved) (NP (-NONE- *-100)) (PP (IN in) (NP (NP (NN trans-activation)) (PP (IN by) (NP (NN p40tax))))) (, ,) (PP (RB possibly) (IN through) (NP (NP (NN binding)) (PP (TO to) (NP (DT an) (ADJP (NN NF-kappa) (JJ B-like)) (JJ nuclear) (NP-COOD (NP (NN factor)) (CC or) (NP (NNS factors)))))))))))) (. .))
(S (NP-SBJ-18 (NP (NN Formation)) (PP (IN of) (NP (DT the) (JJ protein-DNA) (NN complex))) (PP (IN with) (NP (DT the) (NN C26) (NN subfragment)))) (VP (VBD was) (ADVP (RB positively)) (VP (VBN affected) (NP (-NONE- *-18)) (PP (IN by) (NP-LGS (NN p40tax))))) (. .))
(S (NP-SBJ-17 (DT The) (NN C26) (NN element)) (VP (VBD conferred) (NP (NP (JJ partial) (NN responsiveness)) (PP (TO to) (NP (NN p40tax)))) (SBAR-TMP (WHADVP-101 (WRB when)) (S (NP-SBJ-19 (-NONE- *-17)) (VP (VBN linked) (NP (-NONE- *-19)) (PP (TO to) (NP (NP (CD one) (NN copy)) (PP (IN of) (NP (DT the) (JJ 21-bp) (NN element))) (SBAR (WHNP-20 (WDT that)) (, ,) (S (NP-SBJ (-NONE- *T*-20)) (PP (IN by) (NP (PRP itself))) (, ,) (VP (VBD showed) (NP (JJ little) (NN activation)) (PP (IN in) (NN response) (TO to) (NP (NN p40tax)))))))) (ADVP (-NONE- *T*-101)))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-22 (NP (DT the) (NN C26) (NN element)) (ADVP (RB alone))) (, ,) (SBAR-TMP (WHADVP-102 (RB even) (WRB when)) (S (NP-SBJ-23 (-NONE- *-22)) (VP (VBN repeated) (NP (-NONE- *-23)) (ADVP (-NONE- *T*-102))))) (, ,) (VP (MD could) (RB not) (VP (VB be) (VP (VBN activated) (NP (-NONE- *-22)) (PP (IN by) (NP-LGS (NN p40tax))) (, ,) (PP (IN unlike) (NP (JJ other) (ADJP (NN NF-kappa) (JJ B-binding)) (NNS elements)))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-25 (NP (DT the) (NN C26) (NN element)) (NP (PRP itself))) (VP (VBD was) (ADVP (RB profoundly)) (VP (VBN activated) (NP (-NONE- *-25)) (PP-TMP (IN upon) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN 12-O-tetradecanoylphorbol-13-acetate))))))) (. .))
(S (NP-SBJ (DT These) (NNS findings)) (ADVP (RB therefore)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (DT the) (NN HTLV-I) (NN enhancer)) (VP (VBZ contains) (NP (NP (ADJP (JJ multiple) (JJ functional)) (NNS elements)) (, ,) (PP (VBG including) (NP (NP (VBG binding) (NNS sites)) (PP (IN for) (NP (ADJP (IN at) (JJS least)) (ADJP (NN CREB-) (CC and) (NN NF-kappa) (JJ B-like)) (NNS factors))))) (, ,) (SBAR (WHNP-26 (WDT which)) (S (NP-SBJ (-NONE- *T*-26)) (ADVP (RB synergistically)) (VP (VBP cooperate) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN HTLV-I) (NN enhancer))) (PP (IN in) (NN response) (TO to) (NP (NN p40tax))))))))))))) (. .))
(S (NP-SBJ (PRP$ Our) (NNS results)) (ADVP (RB also)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-27 (NP (JJ TPA-dependent) (NN activation)) (PP (IN of) (NP (DT the) (NN HTLV-I) (NN enhancer)))) (VP (MD may) (VP (VB be) (VP (VBN mediated) (NP (-NONE- *-27)) (PP (IN through) (NP (DT the) (NN C26) (NN element))))))))) (. .))
